First Year of Commercialization, Alphamab Oncology Reports Full Year 2021 Financial Results and Business Highlights ...Middle East

PR Newswire - News
SUZHOU, China, March 29, 2022 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) reported financial results for the full year ended December 31, 2021 and highlighted recent progress and upcoming milestones. Highlights First product launch: In November 2021, KN035 (Envafolimab) has...

Read More Details
Finally We wish PressBee provided you with enough information of ( First Year of Commercialization, Alphamab Oncology Reports Full Year 2021 Financial Results and Business Highlights )

Apple Storegoogle play

Also on site :